2 not yet recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1 Semaglutide, Dietary Counseling, Exercise - GLP - 1, Obesity & Overweight | Phase 4 | Not yet recruiting | William Marsh Rice University | 20 | 2026-04-06 | 2026-04-28 |
| Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients Roxadustat, Recombinant human erythropoietin (EPO) - Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD) | Phase 4 | Not yet recruiting | Tianjin Medical University General Hospital | 60 | 2025-09-10 | 2025-09-09 |
Anemia (1) · Muscular Atrophy (1) · Obesity (1) · Overweight (1) · Sarcopenia (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Body Weight (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Muscular Atrophy (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1)
Exercise (1) · Nutrition Assessment (1) · roxadustat (1) · semaglutide (1)
Tianjin Medical University General Hospital (1) · William Marsh Rice University (1)
United States (1)